Krukenberg tumor in a patient treated with biologics for psoriasis

Anca Chiriac,Piotr Brzezinski

doi:10.7241/ourd.20194.32

Abstract

Krukenberg tumor in a patient treated with biologics for psoriasis

Highlights

Krukenberg tumor (KT) is, by definition, any ovarian metastatic carcinoma derived from a primary malignancy [1]
We report a case of 60-year-old female patient, who has been treated, for more than 10 years, with adalimumab for a severe plaque psoriasis and psoriatic arthritis, with close follow-up, every 6 months and good clinical evolution
Particularities of present case are the following: a menopause woman, treated with biologics for many years for psoriasis, evaluated carefully at every 6 months, who was diagnosed with KT

Summary

Introduction

Krukenberg tumor (KT) is, by definition, any ovarian metastatic carcinoma derived from a primary malignancy [1]. The name of the malignancy, that can create confusion in clinical practice, belongs to Friedrich Ernst Krukenberg who described a new form of ovarian cancer in 1896, which proved, to be metastatic, 6 years later [2]. It has been evidenced lately the origin of the KT could be, in most cases, gastric and colorectal cancers, and other sites have been reported, such as breast, small intestine, lung, gallbladder and biliary ducts, urinary tract, pancreas, uterine cervix [2,3].

Results

Conclusion